ARLINGTON, Tenn.--(BUSINESS WIRE)--July 15, 2004--

  Notification Completes Clearance for Products Currently In Wright's
           ALLOMATRIX(R) Line of Allograft Bone Void Fillers

Wright Medical Group, Inc. (NASDAQ:WMGI), a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologic materials, today announced receipt of marketing clearance from the United States Food and Drug Administration (FDA) for ALLOMATRIX(R) C, ALLOMATRIX(R) Custom, and ALLOMATRIX(R) DR bone graft putties that contain demineralized bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips. Following the FDA-clearance of ALLOMATRIX(R) Injectable Putty in March of this year, today's regulatory announcement completes the clearance process for Wright's entire ALLOMATRIX(R) family of products.

The Company began the 510(k) premarket notification process in March of 2002, following FDA's clarification to all allograft putty providers that such products are considered medical devices and are therefore regulated under the federal Food, Drug, and Cosmetic Act. The Company has satisfied FDA's medical device requirements for demonstrating substantial equivalence, including endpoints established for each product's clinical performance and viral inactivation potential. The ALLOMATRIX(R) family of products and OSTEOSET(R) 2 DBM are the only commercially available, FDA-cleared products which contain demineralized bone matrix (DBM).

Laurence Fairey, President and Chief Executive Officer, commented, "Wright Medical has demonstrated a successful strategy of using these specialized formulations to address individual clinical needs targeted at individual orthopaedic sub-specialties. Wright's ability to understand and address specific surgical requirements by developing these focused products reinforces the Company's growing reputation for its comprehensive understanding and responsiveness to the expanding bio-orthopaedic market."

About Wright

Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologic materials. The Company has been in business for more than 50 years and markets its products in over 40 countries worldwide. For more information about Wright, visit our website at www.wmt.com.

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company's filings with the Securities and Exchange Commission (including the Company's annual report on Form 10-K for the year ended December 31, 2003), which could cause the Company's actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.

    CONTACT: Wright Medical Group Inc., Arlington

    SOURCE: Wright Medical Group, Inc.